Fleury (), Diagnostic Medicine Group, registered a net profit of R $ 84 million in the fourth quarter of 2024. The figure is 3.3% higher than the same period of R $ 81.3 million. In the accumulated 2024, however, the growth was more significant, 32%, reaching R $ 616.2 million.
Accounting results encompass Hermes Pardini’s numbers from May 2023, when the transaction with Fleury was completed. Last year was the most relevant to the company in terms of synergies of this merger.
“There are still synergy captures, but not as important as they were 2024. Most of the integration actually happened last year, but we will continue to chase all the opportunities,” Jeane Tsutsui, CEO of the Fleury Group, told the CEO, Infomoney.
With the merger, more than R $ 200 million of increment in EBITDA (English for profit before interest rates, depreciation and amortization) by 2026 and, according to the executive, the company is “in line” with this goal.
Ebitda was R $ 405.4 million in the fourth quarter and R $ 1.982 billion in the year 2024, with growth of 7.9% and 19.6% respectively. The quarterly ebitda margin was 22%, affected by the typical seasonality of the period, but the annual recorded a growth of 1.9 percentage point to 25.8%.
Fleury group’s net revenue between October and December last year advanced 7.9%to $ 1.893 billion. In 2024, the figure was R $ 7.68 billion, with an increase of 18.8%.
Continues after advertising
In diagnostic medicine, gross revenue grew 14.1% in the quarter, to $ 1.353 billion. In the year, it reached R $ 5.599 billion, up 14.1%.
The Fleury brand, which was once the group’s flagship, today accounts for about 25% of the company’s gross revenue. And between October and December, it grew 9.5% over the previous year.
“Today we have grown more in other brands, which is slightly lower than Fleury, but with similar return on capital. […] We don’t just look at the top line“Says Jeane.
Continues after advertising
Gross B2B revenue from hospitals and lab-to-lab grew 5.5% in the quarter, to 465.7 million and 43.5% in the year, to R $ 1.958 billion. And in new links, vertical outpatient services, there was a growth of 3.9% in gross quarter revenues, to R $ 174.9 million, and from 10.2% in the year, to R $ 762.7 million.
The company’s operating expenses advanced 17.5% in the fourth quarter to R $ 252.6 million. And in the year, the Fleury group disbursed R $ 945.4 million, 14.7% more than in 2023.
The Fleury Group’s operational cash flow was $ 1.930 billion in 2024. This helped the company reduce its leverage, although the company made two smaller acquisitions last year – for $ 69.8 million, and Diagnostic Medicine, for $ 130 million. Net debt ended the year worth the EBITDA 1 time and the cost of indebtedness was also lower than the end of 2023.
Continues after advertising
“We continue to follow opportunities [de aquisição] Within our discipline, ”said Jose Antonio Filippo, CFO of Fleury. “Small M&A’s continue, as long as our financial and strategic requirements are met.”
Filippo explains that approximately 47% of the capex The company is invested in digital information technology, one generates an efficiency gain for the company. Examination scheduling and receiving results by application has helped the company reduce service costs.
Read more:
Continues after advertising
According to the executive, the company’s robust cash generation allows Fleury to make capital investments without stirring the leverage, while the company works with a payout (percentage of profit that is distributed to the shareholder).
Fleury will distribute dividends
Along with the result, the Fleury group reported that its board of directors approved the distribution of R $ 254.1 million in dividends. The amount corresponds to R $ 0.4667 per share, excluding roles in treasury. The shareholder will be paid on May 9.
Investors who have the role in closing the trading session next Wednesday (6) will be entitled to the proceed, which enters the account of the mandatory minimum dividend of the fiscal year 2024.
Continues after advertising
Last December, which were paid on the 27th of that same month;
